FTC antitrust enforcement has intensified in the pharmaceutical sector, targeting both pay-for-delay settlements and market allocation agreements among generic manufacturers
To minimize the side effects, escalate the dose of GLP-1 agonist slowly as recommended by your healthcare provider and follow the diet plan provided by your dietician
Medical Disclaimer: This content is for informational and educational purposes only
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials, Diabetes and Metabolism Journal (2019) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA (2022) Once-weekly semaglutide in adults with overweight or obesity, The New England Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension, Diabetes, Obesity and Metabolism (2022) Patient assistance program, Novo Nordisk APC: Find a compounder, Alliance for Pharmacy Compounding (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
This can cause some individuals to experience tingling, numbness, or burning in their skin
Tirzepatide is marketed as Zepbound for weight management and Mounjaro for type 2 diabetes, though Mounjaro is commonly prescribed off-label for weight management